Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2023

22-08-2022 | Laryngoscopy | Original Article

Best Practices in Treatment of Laryngopharyngeal Reflux Disease: A Multidisciplinary Modified Delphi Study

Authors: Afrin N. Kamal, Shumon I. Dhar, Jonathan M. Bock, John O. Clarke, Jerome R. Lechien, Jacqueline Allen, Peter C. Belafsky, Joel H. Blumin, Walter W. Chan, Ronnie Fass, P. Marco Fisichella, Michael Marohn, Ashli K. O’Rourke, Gregory Postma, Edoardo V. Savarino, Michael F. Vaezi, Thomas L. Carroll, Lee M. Akst

Published in: Digestive Diseases and Sciences | Issue 4/2023

Login to get access

Abstract

Background

Laryngopharyngeal reflux (LPR) is a common otolaryngologic diagnosis. Treatment of presumed LPR remains challenging, and limited frameworks exist to guide treatment.

Methods

Using RAND/University of California, Los Angeles (UCLA) Appropriateness Methods, a modified Delphi approach identified consensus statements to guide LPR treatment. Experts independently and blindly scored proposed statements on importance, scientific acceptability, usability, and feasibility in a four-round iterative process. Accepted measures reached scores with ≥ 80% agreement in the 7–9 range (on a 9-point Likert scale) across all four categories.

Results

Fifteen experts rated 36 proposed initial statements. In round one, 10 (27.8%) statements were rated as valid. In round two, 8 statements were modified based on panel suggestions, and experts subsequently rated 5 of these statements as valid. Round three’s discussion refined statements not yet accepted, and in round four, additional voting identified 2 additional statements as valid. In total, 17 (47.2%) best practice statements reached consensus, touching on topics as varied as role of empiric treatment, medication use, lifestyle modifications, and indications for laryngoscopy.

Conclusion

Using a well-tested methodology, best practice statements in the treatment of LPR were identified. The statements serve to guide physicians on LPR treatment considerations.
Literature
1.
go back to reference Franco RA. Laryngopharyngeal reflux. Allergy Asthma Proc 2006;27:21–25.PubMed Franco RA. Laryngopharyngeal reflux. Allergy Asthma Proc 2006;27:21–25.PubMed
2.
go back to reference Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991;101:1–78.PubMedCrossRef Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991;101:1–78.PubMedCrossRef
3.
go back to reference Carroll TL, Werner A, Nahikian K, Dezube A, Roth DF. Rethinking the laryngopharyngeal reflux treatment algorithm: evaluating an alternate empiric dosing regimen and considering up-front, pH-impedance, and manometry testing to minimize cost in treating suspect laryngopharyngeal reflux disease. Laryngoscope 2017;127:S1–S13.PubMedCrossRef Carroll TL, Werner A, Nahikian K, Dezube A, Roth DF. Rethinking the laryngopharyngeal reflux treatment algorithm: evaluating an alternate empiric dosing regimen and considering up-front, pH-impedance, and manometry testing to minimize cost in treating suspect laryngopharyngeal reflux disease. Laryngoscope 2017;127:S1–S13.PubMedCrossRef
4.
go back to reference Spantideas N, Drosou E, Bougea A, AlAbdulwahed R. Proton pump inhibitors for the treatment of laryngopharyngeal reflux. A systematic review. J Voice 2020;34:918–929.PubMedCrossRef Spantideas N, Drosou E, Bougea A, AlAbdulwahed R. Proton pump inhibitors for the treatment of laryngopharyngeal reflux. A systematic review. J Voice 2020;34:918–929.PubMedCrossRef
5.
go back to reference Campagnolo AM, Priston J, Thoen RH, Medeiros T, Assunção AR. Laryngopharyngeal reflux: diagnosis, treatment, and latest research. Int Arch Otorhinolaryngol 2014;18:184–191.PubMed Campagnolo AM, Priston J, Thoen RH, Medeiros T, Assunção AR. Laryngopharyngeal reflux: diagnosis, treatment, and latest research. Int Arch Otorhinolaryngol 2014;18:184–191.PubMed
7.
go back to reference Hand Surgery Quality Consortium. Candidate quality measures for hand surgery. J Hand Surg 2017;42:859–866.e3.CrossRef Hand Surgery Quality Consortium. Candidate quality measures for hand surgery. J Hand Surg 2017;42:859–866.e3.CrossRef
8.
go back to reference Yadlapati R, Dakhoul L, Pandolfino JE, Keswani RN. The quality of care for gastroesophageal reflux disease. Dig Dis Sci 2017;62:569–576.PubMedCrossRef Yadlapati R, Dakhoul L, Pandolfino JE, Keswani RN. The quality of care for gastroesophageal reflux disease. Dig Dis Sci 2017;62:569–576.PubMedCrossRef
9.
go back to reference Ness-Jensen E, Hveem K, El-Serag H, Lagergren J. Lifestyle intervention in gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2016;14:175–182.PubMedCrossRef Ness-Jensen E, Hveem K, El-Serag H, Lagergren J. Lifestyle intervention in gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2016;14:175–182.PubMedCrossRef
10.
go back to reference Lechien JR, Bobin F, Muls V et al. Patients with acid, high-fat and low-protein diet have higher laryngopharyngeal reflux episodes at the impedance-pH monitoring. Eur Arch Otorhinolaryngol 2020;277:511–520.PubMedCrossRef Lechien JR, Bobin F, Muls V et al. Patients with acid, high-fat and low-protein diet have higher laryngopharyngeal reflux episodes at the impedance-pH monitoring. Eur Arch Otorhinolaryngol 2020;277:511–520.PubMedCrossRef
11.
go back to reference Koufman JA. Low-acid diet for recalcitrant laryngopharyngeal reflux: therapeutic benefits and their implications. Ann Otol Rhinol Laryngol 2011;120:281–287.PubMedCrossRef Koufman JA. Low-acid diet for recalcitrant laryngopharyngeal reflux: therapeutic benefits and their implications. Ann Otol Rhinol Laryngol 2011;120:281–287.PubMedCrossRef
13.
go back to reference Koufman JA, Johnston N. Potential benefits of pH 8.8 alkaline drinking water as an adjunct in the treatment of reflux disease. Ann Otol Rhinol Laryngol 2012;121:431–434.PubMedCrossRef Koufman JA, Johnston N. Potential benefits of pH 8.8 alkaline drinking water as an adjunct in the treatment of reflux disease. Ann Otol Rhinol Laryngol 2012;121:431–434.PubMedCrossRef
14.
go back to reference Zalvan CH, Hu S, Greenberg B, Geliebter J. A comparison of alkaline water and mediterranean diet vs proton pump inhibition for treatment of laryngopharyngeal reflux. JAMA Otolaryngol Head Neck Surg 2017;143:1023–1029.PubMedPubMedCentralCrossRef Zalvan CH, Hu S, Greenberg B, Geliebter J. A comparison of alkaline water and mediterranean diet vs proton pump inhibition for treatment of laryngopharyngeal reflux. JAMA Otolaryngol Head Neck Surg 2017;143:1023–1029.PubMedPubMedCentralCrossRef
15.
go back to reference Fritz MA, Persky MJ, Fang Y et al. The accuracy of the laryngopharyngeal reflux diagnosis: utility of the stroboscopic exam. Otolaryngol Head Neck Surg 2016;155:629–634.PubMedCrossRef Fritz MA, Persky MJ, Fang Y et al. The accuracy of the laryngopharyngeal reflux diagnosis: utility of the stroboscopic exam. Otolaryngol Head Neck Surg 2016;155:629–634.PubMedCrossRef
16.
go back to reference Sulica L. Hoarseness misattributed to reflux: sources and patterns of error. Ann Otol Rhinol Laryngol 2014;123:442–445.PubMedCrossRef Sulica L. Hoarseness misattributed to reflux: sources and patterns of error. Ann Otol Rhinol Laryngol 2014;123:442–445.PubMedCrossRef
17.
go back to reference Agrawal N, Yadlapati R, Shabeeb N et al. Relationship between extralaryngeal endoscopic findings, proton pump inhibitor (PPI) response, and pH measures in suspected laryngopharyngeal reflux. Dis Esophagus 2019;32:doy072.PubMedCrossRef Agrawal N, Yadlapati R, Shabeeb N et al. Relationship between extralaryngeal endoscopic findings, proton pump inhibitor (PPI) response, and pH measures in suspected laryngopharyngeal reflux. Dis Esophagus 2019;32:doy072.PubMedCrossRef
18.
go back to reference Powell J, Cocks HC. Mucosal changes in laryngopharyngeal reflux–prevalence, sensitivity, specificity and assessment. Laryngoscope 2013;123:985–991.PubMedCrossRef Powell J, Cocks HC. Mucosal changes in laryngopharyngeal reflux–prevalence, sensitivity, specificity and assessment. Laryngoscope 2013;123:985–991.PubMedCrossRef
19.
go back to reference Milstein CF, Charbel S, Hicks DM et al. Prevalence of laryngeal irritation signs associated with reflux in asymptomatic volunteers: impact of endoscopic technique (rigid vs. flexible laryngoscope). Laryngoscope 2005;115:2256–2261.PubMedCrossRef Milstein CF, Charbel S, Hicks DM et al. Prevalence of laryngeal irritation signs associated with reflux in asymptomatic volunteers: impact of endoscopic technique (rigid vs. flexible laryngoscope). Laryngoscope 2005;115:2256–2261.PubMedCrossRef
20.
go back to reference Branski RC, Bhattacharyya N, Shapiro J. The reliability of the assessment of endoscopic laryngeal findings associated with laryngopharyngeal reflux disease. Laryngoscope 2002;112:1019–1024.PubMedCrossRef Branski RC, Bhattacharyya N, Shapiro J. The reliability of the assessment of endoscopic laryngeal findings associated with laryngopharyngeal reflux disease. Laryngoscope 2002;112:1019–1024.PubMedCrossRef
21.
go back to reference Hicks DM, Ours TM, Abelson TI, Vaezi MF, Richter JE. The prevalence of hypopharynx findings associated with gastroesophageal reflux in normal volunteers. J Voice 2002;16:564–579.PubMedCrossRef Hicks DM, Ours TM, Abelson TI, Vaezi MF, Richter JE. The prevalence of hypopharynx findings associated with gastroesophageal reflux in normal volunteers. J Voice 2002;16:564–579.PubMedCrossRef
22.
go back to reference Belafsky PC, Postma GN, Koufman JA. The validity and reliability of the reflux finding score (RFS). Laryngoscope 2001;111:1313–1317.PubMedCrossRef Belafsky PC, Postma GN, Koufman JA. The validity and reliability of the reflux finding score (RFS). Laryngoscope 2001;111:1313–1317.PubMedCrossRef
23.
go back to reference Lechien JR, Rodriguez Ruiz A, Dequanter D et al. Validity and reliability of the reflux sign assessment. Ann Otol Rhinol Laryngol 2020;129:313–325.PubMedCrossRef Lechien JR, Rodriguez Ruiz A, Dequanter D et al. Validity and reliability of the reflux sign assessment. Ann Otol Rhinol Laryngol 2020;129:313–325.PubMedCrossRef
24.
go back to reference Koufman JA, Aviv JE, Casiano RR, Shaw GY. Laryngopharyngeal reflux: position statement of the committee on speech, voice, and swallowing disorders of the American Academy of Otolaryngology-Head and Neck Surgery. Otolaryngol Head Neck Surg 2002;127:32–35.PubMedCrossRef Koufman JA, Aviv JE, Casiano RR, Shaw GY. Laryngopharyngeal reflux: position statement of the committee on speech, voice, and swallowing disorders of the American Academy of Otolaryngology-Head and Neck Surgery. Otolaryngol Head Neck Surg 2002;127:32–35.PubMedCrossRef
25.
go back to reference Lechien JR, Allen JE, Barillari MR et al. Management of laryngopharyngeal reflux around the world: an international study. Laryngoscope 2021;131:E1589–E1597.PubMedCrossRef Lechien JR, Allen JE, Barillari MR et al. Management of laryngopharyngeal reflux around the world: an international study. Laryngoscope 2021;131:E1589–E1597.PubMedCrossRef
26.
go back to reference Guo H, Ma H, Wang J. Proton pump inhibitor therapy for the treatment of laryngopharyngeal reflux: a meta-analysis of randomized controlled trials. J Clin Gastroenterol 2016;50:295–300.PubMedCrossRef Guo H, Ma H, Wang J. Proton pump inhibitor therapy for the treatment of laryngopharyngeal reflux: a meta-analysis of randomized controlled trials. J Clin Gastroenterol 2016;50:295–300.PubMedCrossRef
27.
go back to reference Akst LM, Haque OJ, Clarke JO et al. The changing impact of gastroesophageal reflux disease in clinical practice. Ann Otol Rhinol Laryngol 2017;126:229–235.PubMedCrossRef Akst LM, Haque OJ, Clarke JO et al. The changing impact of gastroesophageal reflux disease in clinical practice. Ann Otol Rhinol Laryngol 2017;126:229–235.PubMedCrossRef
28.
go back to reference Welage LS. Overview of pharmacologic agents for acid suppression in critically ill patients. Am J Health Syst Pharm 2005;62:S4–S10.PubMedCrossRef Welage LS. Overview of pharmacologic agents for acid suppression in critically ill patients. Am J Health Syst Pharm 2005;62:S4–S10.PubMedCrossRef
30.
go back to reference Lechien JR, Finck C, Khalife M et al. Change of signs, symptoms and voice quality evaluations throughout a 3- to 6-month empirical treatment for laryngopharyngeal reflux disease. Clin Otolaryngol 2018;43:1273–1282.PubMedCrossRef Lechien JR, Finck C, Khalife M et al. Change of signs, symptoms and voice quality evaluations throughout a 3- to 6-month empirical treatment for laryngopharyngeal reflux disease. Clin Otolaryngol 2018;43:1273–1282.PubMedCrossRef
31.
go back to reference Carroll TL, Fedore LW, Aldahlawi MM. pH Impedance and high-resolution manometry in laryngopharyngeal reflux disease high-dose proton pump inhibitor failures. Laryngoscope 2012;122:2473–2481.PubMedCrossRef Carroll TL, Fedore LW, Aldahlawi MM. pH Impedance and high-resolution manometry in laryngopharyngeal reflux disease high-dose proton pump inhibitor failures. Laryngoscope 2012;122:2473–2481.PubMedCrossRef
32.
33.
go back to reference Lechien JR, Akst LM, Hamdan AL et al. Evaluation and management of laryngopharyngeal reflux disease: state of the art review. Otolaryngol Head Neck Surg 2019;160:762–782.PubMedCrossRef Lechien JR, Akst LM, Hamdan AL et al. Evaluation and management of laryngopharyngeal reflux disease: state of the art review. Otolaryngol Head Neck Surg 2019;160:762–782.PubMedCrossRef
34.
go back to reference Snow G, Dhar SI, Akst LM. How to understand and treat laryngopharyngeal reflux. Gastroenterol Clin North Am 2021;50:871–884.PubMedCrossRef Snow G, Dhar SI, Akst LM. How to understand and treat laryngopharyngeal reflux. Gastroenterol Clin North Am 2021;50:871–884.PubMedCrossRef
35.
go back to reference Noordzij JP, Khidr A, Evans BA et al. Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study. Laryngoscope 2001;111:2147–2151.PubMedCrossRef Noordzij JP, Khidr A, Evans BA et al. Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study. Laryngoscope 2001;111:2147–2151.PubMedCrossRef
36.
go back to reference Park W, Hicks DM, Khandwala F et al. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response. Laryngoscope 2005;115:1230–1238.PubMedCrossRef Park W, Hicks DM, Khandwala F et al. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response. Laryngoscope 2005;115:1230–1238.PubMedCrossRef
37.
go back to reference Freedberg DE, Kim LS, Yang Y-X. The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association. Gastroenterology 2017;152:706–715.PubMedCrossRef Freedberg DE, Kim LS, Yang Y-X. The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association. Gastroenterology 2017;152:706–715.PubMedCrossRef
38.
go back to reference McRorie JW, Kirby JA, Miner PB. Histamine2-receptor antagonists: rapid development of tachyphylaxis with repeat dosing. World J Gastrointest Pharmacol Ther 2014;5:57–62.PubMedPubMedCentralCrossRef McRorie JW, Kirby JA, Miner PB. Histamine2-receptor antagonists: rapid development of tachyphylaxis with repeat dosing. World J Gastrointest Pharmacol Ther 2014;5:57–62.PubMedPubMedCentralCrossRef
39.
go back to reference Wagner JA, Dinh JC, Lightdale JR, Gold BD, Colombo JM. Is this the end for ranitidine? NDMA presence continues to confound. Clin Transl Sci 2021;14:1197–1200.PubMedPubMedCentralCrossRef Wagner JA, Dinh JC, Lightdale JR, Gold BD, Colombo JM. Is this the end for ranitidine? NDMA presence continues to confound. Clin Transl Sci 2021;14:1197–1200.PubMedPubMedCentralCrossRef
40.
go back to reference Florian J, Matta MK, DePalma R et al. Effect of oral ranitidine on urinary excretion of N-Nitrosodimethylamine (NDMA): a randomized clinical trial. JAMA 2021;326:240–249.PubMedCrossRef Florian J, Matta MK, DePalma R et al. Effect of oral ranitidine on urinary excretion of N-Nitrosodimethylamine (NDMA): a randomized clinical trial. JAMA 2021;326:240–249.PubMedCrossRef
42.
go back to reference McKinley SK, Dirks RC, Walsh D et al. Surgical treatment of GERD: systematic review and meta-analysis. Surg Endosc 2021;35:4095–4123.PubMedCrossRef McKinley SK, Dirks RC, Walsh D et al. Surgical treatment of GERD: systematic review and meta-analysis. Surg Endosc 2021;35:4095–4123.PubMedCrossRef
43.
go back to reference Shaker R, Babaei A, Naini SR. Prevention of esophagopharyngeal reflux by augmenting the upper esophageal sphincter pressure barrier. Laryngoscope 2014;124:2268–2274.PubMedPubMedCentralCrossRef Shaker R, Babaei A, Naini SR. Prevention of esophagopharyngeal reflux by augmenting the upper esophageal sphincter pressure barrier. Laryngoscope 2014;124:2268–2274.PubMedPubMedCentralCrossRef
44.
go back to reference Yadlapati R, Pandolfino JE, Greytak M et al. Upper esophageal sphincter compression device as an adjunct to proton pump inhibition for laryngopharyngeal reflux. Dig Dis Sci 2022;67:3045–3054.PubMedCrossRef Yadlapati R, Pandolfino JE, Greytak M et al. Upper esophageal sphincter compression device as an adjunct to proton pump inhibition for laryngopharyngeal reflux. Dig Dis Sci 2022;67:3045–3054.PubMedCrossRef
45.
go back to reference Facs BAJ. Preoperative diagnostic workup before antireflux surgery: an evidence and experience-based consensus of the esophageal diagnostic advisory panel. J Am Coll Surg 2013;217:12. Facs BAJ. Preoperative diagnostic workup before antireflux surgery: an evidence and experience-based consensus of the esophageal diagnostic advisory panel. J Am Coll Surg 2013;217:12.
46.
go back to reference Speyer R, Cordier R, Kertscher B, Heijnen BJ. Psychometric properties of questionnaires on functional health status in oropharyngeal dysphagia: a systematic literature review. BioMed Res Int 2014;2014:1–11.CrossRef Speyer R, Cordier R, Kertscher B, Heijnen BJ. Psychometric properties of questionnaires on functional health status in oropharyngeal dysphagia: a systematic literature review. BioMed Res Int 2014;2014:1–11.CrossRef
47.
go back to reference Laliberte AS, Louie BE, Wilshire CL et al. Ineffective esophageal motility is not a contraindication to total fundoplication. Surg Endosc 2021;35:4811–4816.PubMedCrossRef Laliberte AS, Louie BE, Wilshire CL et al. Ineffective esophageal motility is not a contraindication to total fundoplication. Surg Endosc 2021;35:4811–4816.PubMedCrossRef
48.
go back to reference Gockel I, Rabe SM, Niebisch S. Before and after esophageal surgery: which information is needed from the functional laboratory. VIS 2018;34:116–121. Gockel I, Rabe SM, Niebisch S. Before and after esophageal surgery: which information is needed from the functional laboratory. VIS 2018;34:116–121.
49.
go back to reference Schwameis K, Oh D, Green KM et al. Clinical outcome after laparoscopic Nissen fundoplication in patients with GERD and PPI refractory heartburn. Dis Esophagus 2020;33:doz099.PubMedCrossRef Schwameis K, Oh D, Green KM et al. Clinical outcome after laparoscopic Nissen fundoplication in patients with GERD and PPI refractory heartburn. Dis Esophagus 2020;33:doz099.PubMedCrossRef
50.
go back to reference Carroll TL, Nahikian K, Asban A, Wiener D. Nissen fundoplication for laryngopharyngeal reflux after patient selection using dual pH, full column impedance testing: a pilot study. Ann Otol Rhinol Laryngol 2016;125:722–728.PubMedCrossRef Carroll TL, Nahikian K, Asban A, Wiener D. Nissen fundoplication for laryngopharyngeal reflux after patient selection using dual pH, full column impedance testing: a pilot study. Ann Otol Rhinol Laryngol 2016;125:722–728.PubMedCrossRef
51.
go back to reference Park A, Weltz AS, Sanford Z, Addo A, Zahiri HR. Laparoscopic antireflux surgery (LARS) is highly effective in the treatment of select patients with chronic cough. Surgery 2019;166:34–40.PubMedCrossRef Park A, Weltz AS, Sanford Z, Addo A, Zahiri HR. Laparoscopic antireflux surgery (LARS) is highly effective in the treatment of select patients with chronic cough. Surgery 2019;166:34–40.PubMedCrossRef
52.
go back to reference Zhang C, Hu ZW, Yan C et al. Nissen fundoplication vs proton pump inhibitors for laryngopharyngeal reflux based on pH-monitoring and symptom-scale. World J Gastroenterol 2017;23:3546–3555.PubMedPubMedCentralCrossRef Zhang C, Hu ZW, Yan C et al. Nissen fundoplication vs proton pump inhibitors for laryngopharyngeal reflux based on pH-monitoring and symptom-scale. World J Gastroenterol 2017;23:3546–3555.PubMedPubMedCentralCrossRef
53.
go back to reference Lechien JR, Bock JM, Carroll TL, Akst LM. Is empirical treatment a reasonable strategy for laryngopharyngeal reflux? A contemporary review. Clin Otolaryngol 2020;45:450–458.PubMedCrossRef Lechien JR, Bock JM, Carroll TL, Akst LM. Is empirical treatment a reasonable strategy for laryngopharyngeal reflux? A contemporary review. Clin Otolaryngol 2020;45:450–458.PubMedCrossRef
54.
go back to reference Zerbib F, Bredenoord AJ, Fass R et al. ESNM/ANMS consensus paper: diagnosis and management of refractory gastro-esophageal reflux disease. Neurogastroenterol Motil 2021;33:e14075.PubMedCrossRef Zerbib F, Bredenoord AJ, Fass R et al. ESNM/ANMS consensus paper: diagnosis and management of refractory gastro-esophageal reflux disease. Neurogastroenterol Motil 2021;33:e14075.PubMedCrossRef
55.
go back to reference Ciprandi G, Damiani V, Passali FM et al. Magnesium alginate in patients with laryngopharyngeal reflux. J Biol Regul Homeost Agents 2021;35:61–64.PubMed Ciprandi G, Damiani V, Passali FM et al. Magnesium alginate in patients with laryngopharyngeal reflux. J Biol Regul Homeost Agents 2021;35:61–64.PubMed
56.
go back to reference van der Westhuizen L, Von SJ, Wilkerson BJ et al. Impact of Nissen fundoplication on laryngopharyngeal reflux symptoms. Am Surg 2011;77:878–882.PubMedCrossRef van der Westhuizen L, Von SJ, Wilkerson BJ et al. Impact of Nissen fundoplication on laryngopharyngeal reflux symptoms. Am Surg 2011;77:878–882.PubMedCrossRef
57.
go back to reference Trad KS, Turgeon DG, Deljkich E. Long-term outcomes after transoral incisionless fundoplication in patients with GERD and LPR symptoms. Surg Endosc 2012;26:650–660.PubMedCrossRef Trad KS, Turgeon DG, Deljkich E. Long-term outcomes after transoral incisionless fundoplication in patients with GERD and LPR symptoms. Surg Endosc 2012;26:650–660.PubMedCrossRef
60.
go back to reference Kahrilas PJ, Shaheen NJ, Vaezi MF. American Gastroenterological Association medical position statement on the management of gastroesophageal reflux disease. Gastroenterology 2008;135:1383–1391.PubMedCrossRef Kahrilas PJ, Shaheen NJ, Vaezi MF. American Gastroenterological Association medical position statement on the management of gastroesophageal reflux disease. Gastroenterology 2008;135:1383–1391.PubMedCrossRef
Metadata
Title
Best Practices in Treatment of Laryngopharyngeal Reflux Disease: A Multidisciplinary Modified Delphi Study
Authors
Afrin N. Kamal
Shumon I. Dhar
Jonathan M. Bock
John O. Clarke
Jerome R. Lechien
Jacqueline Allen
Peter C. Belafsky
Joel H. Blumin
Walter W. Chan
Ronnie Fass
P. Marco Fisichella
Michael Marohn
Ashli K. O’Rourke
Gregory Postma
Edoardo V. Savarino
Michael F. Vaezi
Thomas L. Carroll
Lee M. Akst
Publication date
22-08-2022
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2023
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-022-07672-9

Other articles of this Issue 4/2023

Digestive Diseases and Sciences 4/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.